Skip to main content
Published in:

09-05-2024 | Letter to the Editor

Reply to Letter to the Editor ‘Osteosarcopenia: Adjust for the BMI or Bare the Bias’

Authors: Tine Kolenda Paulin, Linnea Malmgren, Fiona E. McGuigan, Kristina E. Åkesson

Published in: Calcified Tissue International | Issue 6/2024

Login to get access


To the Editor, …
Reply to Letter to the Editor ‘Osteosarcopenia: Adjust for the BMI or Bare the Bias’
Tine Kolenda Paulin
Linnea Malmgren
Fiona E. McGuigan
Kristina E. Åkesson
Publication date
Springer US
Published in
Calcified Tissue International / Issue 6/2024
Print ISSN: 0171-967X
Electronic ISSN: 1432-0827

Other articles of this Issue 6/2024

Calcified Tissue International 6/2024 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare
Live Webinar | 01-10-2024 | 12:30 (CEST)

Recent advances in the use of CAR T-cell therapies in relapsed/refractory diffuse large B-cell lymphoma and follicular lymphoma

Live: Tuesday 1st October 2024, 12:30-14:00 (CEST)

In this live webinar, Professor Martin Dreyling and an esteemed, international panel of CAR-T experts will discuss the very latest data on the safety, efficacy and clinical impact of CAR T-cell therapies in the treatment of r/r DLBCL and r/r FL, as presented at ASH 2023, EU CAR-T 2024, and EHA 2024. 

Please note, this webinar is not intended for healthcare professionals based in the US and UK.

Sponsored by: Novartis Pharma AG

Chaired by: Prof. Martin Dreyling
Developed by: Springer Healthcare